| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;92:1651-1664.)
© 1995 American Heart Association, Inc.
Articles |
The Proarrhythmic Potential of Implantable Cardioverter-Defibrillators
From the Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio.
Correspondence to Sergio L. Pinski, MD, Cleveland Clinic Foundation, Department of Cardiology, Desk F15, 9500 Euclid Ave, Cleveland, OH 4419. Email pinskis@ccsmtp.ccf.org.
Abstract The implantable cardioverter-defibrillator (ICD) is remarkably effective in preventing sudden cardiac death in high-risk patients, but it also has the capacity to provoke or worsen cardiac arrhythmias. Tachyarrhythmias or bradyarrhythmias may result from the delivery of antitachycardia or antibradycardia therapies by tiered-therapy defibrillators. This proarrhythmia, although rarely fatal, increases the morbidity associated with defibrillator therapy. Proarrhythmia is related as much to suboptimal programming as to technical limitations of the device. The proarrhythmic potential of ICD therapy can be minimized by tailoring the "electrical prescription" according to characteristics of the clinical arrhythmia and individual ICD idiosyncrasies.
This article has been cited by other articles:
 |
|
 |
|
  S. K. Mulpuru, H. Fujita, and C. Saponieri Rate smoothing induced ventricular arrhythmia and syncope: a new device-induced proarrhythmia Europace, November 10, 2009; (2009) eup356v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Andrikopoulos, S. Tzeis, G. Theodorakis, and P. Vardas Monitoring capabilities of cardiac rhythm management devices Europace, October 29, 2009; (2009) eup317v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Spencker, N. Coban, L. Koch, A. Schirdewan, and D. Muller Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure Europace, April 1, 2009; 11(4): 483 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tung, P. Zimetbaum, and M. E. Josephson A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1111 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Wilkoff, B. D. Williamson, R. S. Stern, S. L. Moore, F. Lu, S. W. Lee, U. M. Birgersdotter-Green, M. S. Wathen, I. C. Van Gelder, B. M. Heubner, et al. Strategic Programming of Detection and Therapy Parameters in Implantable Cardioverter-Defibrillators Reduces Shocks in Primary Prevention Patients: Results From the PREPARE (Primary Prevention Parameters Evaluation) Study J. Am. Coll. Cardiol., August 12, 2008; 52(7): 541 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Eckstein, M. T. Koller, M. Zabel, D. Kalusche, B. A. Schaer, S. Osswald, and C. Sticherling Necessity for Surgical Revision of Defibrillator Leads Implanted Long-Term: Causes and Management Circulation, May 27, 2008; 117(21): 2727 - 2733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Almendral and M. E. Josephson All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator Circulation, September 4, 2007; 116(10): 1204 - 1212. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Abello, J. L. Merino, R. Peinado, M. Gnoatto, M. A. Arias, M. Gonzalez-Vasserot, and J. A. Sobrino Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia Eur. Heart J., January 1, 2006; 27(1): 89 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vollmann, A. Erdogan, E. Himmrich, J. Neuzner, D. Becker, C. Unterberg-Buchwald, J. Sperzel, and for the SAFE Study Investigators Patient AlertTM to detect ICD lead failure: efficacy, limitations, and implications for future algorithms. Europace, January 1, 2006; 8(5): 371 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bansch, F. Steffgen, G. Gronefeld, C. Wolpert, D. Bocker, R.-U. Mletzko, W. Schols, K. Seidl, M. Piel, F. Ouyang, et al. The 1+1 Trial: A Prospective Trial of a Dual- Versus a Single-Chamber Implantable Defibrillator in Patients With Slow Ventricular Tachycardias Circulation, August 31, 2004; 110(9): 1022 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kouakam, S. Kacet, J.-R. Hazard, A. Ferraci, H. Mansour, P. Defaye, J.-M. Davy, M. Lambiez, and on behalf of the Ventak AV Investigators Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia Europace, January 1, 2004; 6(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. M. J. Theuns, J. C. J. Res, and L. J. Jordaens Home monitoring in ICD therapy: future perspectives Europace, January 1, 2003; 5(2): 139 - 142. [Abstract] [PDF]
|
|
|
|
|
|
E. Garcia-Moran, L. Mont, A. Cuesta, M. Matas, and J. Brugada Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator Eur. Heart J., June 1, 2002; 23(11): 901 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Pires, M. H. Lehmann, R. T. Steinman, J. J. Baga, C. D. Schuger, and Participating Investigators Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses J. Am. Coll. Cardiol., January 1, 1999; 33(1): 24 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sticherling, A. Schaumann, T. Klingenheben, S. H. Hohnloser, and for the Ventak AV II DR investigators First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator: Advantages and complications Europace, January 1, 1999; 1(2): 96 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 D Babuty, L Fauchier, and P Cosnay Inappropriate shocks delivered by implantable cardiac defibrillators during oversensing of activity of diaphagmatic muscle Heart, January 1, 1999; 81(1): 94 - 96. [Abstract] [Full Text]
|
|
|
|
|
|
A. E. Epstein, G. N. Kay, V. J. Plumb, S. M. Dailey, and P. G. Anderson Gross and Microscopic Pathological Changes Associated With Nonthoracotomy Implantable Defibrillator Leads Circulation, October 13, 1998; 98(15): 1517 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rosenqvist, T. Beyer, M. Block, K. den Dulk, J. Minten, and F. Lindemans Adverse Events With Transvenous Implantable Cardioverter-Defibrillators : A Prospective Multicenter Study Circulation, August 18, 1998; 98(7): 663 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Stevenson, P. L. Friedman, and M. O. Sweeney Catheter Ablation as an Adjunct to ICD Therapy Circulation, September 2, 1997; 96(5): 1378 - 1380. [Full Text]
|
|
|
|
 |
|
 N. Coupland, S. Wilson, and D. Nutt Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems J Psychopharmacol, January 1, 1997; 11(1): 83 - 92. [PDF]
|
|
|
|
|
|
G. J. Fahy, E. B. Sgarbossa, P. J. Tchou, and S. L. Pinski Hospital Readmission in Patients Treated With Tiered-Therapy Implantable Defibrillators Circulation, September 15, 1996; 94(6): 1350 - 1356. [Abstract] [Full Text]
|
|